Leading where
medicine is going
medicine is going
Inspired by patients, we apply rigorous science to address the serious health problems of today and develop the medicines of tomorrow.
We’re surfacing patterns in data to discover and deliver new treatments more efficiently.
Reimagining how we discover and develop transformational treatments, accelerating the path from lab to life and advancing the standard of care.
We’re taking on the world’s most challenging diseases with treatments specifically tailored to the patients we serve.
Our impact
180M+
Patients treated globally with one of our medicines
$12B
invested in R&D
#1
in Innovation*
*2023 Idea pharma
innovation index
#1
in BioPharma Dealmaking*
*1H2024 IQVIA pharma
deals white paper
Our innovation
Fueled by data and endless curiosity, we’re reimagining treatments for the most complex diseases of our time.
We’re transforming possibilities and improving patient outcomes - even for diseases once thought untreatable. It’s about offering hope where it was once scarce, and improving lives through targeted, personalized care.
We’re re-inventing the clinical trial experience by striving to develop and implement new approaches, technologies, and ways of working.
We aim to deliver truly remarkable medicines that provide value to patients, healthcare professionals and healthcare systems.
We’re transforming how we discover, develop and deliver new therapies — helping bring transformative medicines to people around the world.
Our team targets the hardest-to-treat diseases to turn complex therapeutic concepts into transformational therapies for patients.
Focus areas
Our scientists and researchers are pioneering the path from lab to life and championing patients each step of the way.
We’re helping patients with immune-mediated disease reclaim their lives by delivering transformational and accessible therapies.
Our mission is to help reduce the burden, disability and devastation caused by serious neuropsychiatric and neurodegenerative diseases.
We have an unrelenting vision to ease the tremendous global burden of cardiovascular disease and pulmonary hypertension. We look to advance therapies that improve lives, change the treatment paradigm, enable access and offer hope to patients living with these diseases.
We won’t stop striving until we restore and preserve vision for those living with retinal diseases.
Featured articles
We are pioneering the path from lab to life and championing patients each step of the way.
We’re always looking for new partners to help solve some of the world’s greatest healthcare problems.
If you have questions, would like materials, or need to report an adverse event, please reach out below.